Indications for use
Benign hyperplasia and adenocarcinoma of the prostate gland.
Method of use and dosage
In benign prostatic hyperplasia (BPH) 80 mg 3 times a day for 30 days. If necessary, within a year, another 1-3 courses with an interval of 1-3 months.
In adenocarcinoma of prostate gland use 80 mg 3 times a day for 60 days. The total dose and duration of treatment depends on the changes in the prostate gland, the presence or absence of metastases and the general condition of the patient.
